CIK 0002007919 · <br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $6,347,357
- in 7 filings
- Open-market sales, last 90 days
- $279,010
- in 2 filings
Net +$6,068,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | FORSYTH DOUGLAS Director | Purchase | +2,500 | $114.65 | $287K | 227,064 |
| 2026-06-03 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2026-06-03 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-05-28 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-08-23 | FORSYTH DOUGLAS Director | Purchase | +59,812 | $14.07 | $842K | 224,564 |
| 2024-08-22 | FORSYTH DOUGLAS Director | Purchase | +15,188 | $12.89 | $196K | 164,752 |
| 2024-05-30 | FORSYTH DOUGLAS Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-05-29 | FORSYTH DOUGLAS Director | Grant or award | +149,564 | 149,564 |
Page 1 of 1 · 8 trades